StockNews.com began coverage on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a report issued on Wednesday morning. The brokerage issued a sell rating on the biotechnology company’s stock.
22nd Century Group Price Performance
22nd Century Group stock opened at $0.09 on Wednesday. The company has a market capitalization of $4.27 million, a PE ratio of 0.00 and a beta of 1.45. 22nd Century Group has a 12-month low of $0.09 and a 12-month high of $5.69. The firm’s fifty day moving average is $0.18 and its 200 day moving average is $0.62. The company has a quick ratio of 0.67, a current ratio of 1.09 and a debt-to-equity ratio of 1.59.
22nd Century Group (NASDAQ:XXII – Get Free Report) last released its quarterly earnings data on Tuesday, November 12th. The biotechnology company reported ($0.54) earnings per share (EPS) for the quarter. 22nd Century Group had a negative return on equity of 380.39% and a negative net margin of 144.09%. The company had revenue of $5.95 million for the quarter.
Institutional Trading of 22nd Century Group
About 22nd Century Group
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Featured Articles
- Five stocks we like better than 22nd Century Group
- Investing in Travel Stocks Benefits
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- What Are the FAANG Stocks and Are They Good Investments?
- Top-Performing Non-Leveraged ETFs This Year
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.